0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98โ99% purity (HPLC).
Store 2โ8 ยฐC (โคโ20 ยฐC long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$165.00
This product is available by prescription only
This product does not require a prescription
Each peptide batch is tested and verified to meet or exceed 98โ99% purity (HPLC).
Store 2โ8 ยฐC (โคโ20 ยฐC long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Retatrutide peptide is sourced by research teams investigating how a single synthetic compound simultaneously engages three pharmacologically distinct receptor systems within controlled in vitro environments. GIPR, GLP-1R, and GCGR โ the glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor respectively โ are class B G protein-coupled receptors studied extensively in metabolic signaling and energy regulation research models.
Each receptor activates overlapping but distinct intracellular signaling profiles when engaged individually. Retatrutide’s tri-receptor architecture makes it a research tool for investigating how concurrent activation of all three receptor pathways within the same cell-based system produces signaling outputs that differ from those generated by selective mono- or dual-agonist compounds. This multi-pathway convergence is the primary mechanistic question under investigation in Retatrutide-based laboratory research.
The 15mg format is designed for laboratories that have established their assay parameters using smaller quantities and are scaling to full multi-arm experimental protocols โ including parallel single-receptor, dual-receptor, and triple-receptor activation comparisons within the same research programme.
Retatrutide peptide is investigated in research environments for its concurrent engagement of GIPR, GLP-1R, and GCGR receptor systems expressed in recombinant cell platforms and relevant primary cell models. It is studied within controlled laboratory models examining cyclic AMP accumulation dynamics โ cyclic AMP is a second messenger molecule that relays receptor-level binding events into the cell interior โ across all three receptor pathways simultaneously, and how tri-receptor co-activation modulates downstream effector protein responses relative to individual receptor stimulation.
The compound is explored for experimental peptide research involving comparative agonist potency profiling across the incretin and glucagon receptor families. Incretin receptors โ GIPR and GLP-1R โ are studied for their roles in glucose-dependent signaling; GCGR is studied for its role in energy substrate mobilisation signaling. Retatrutide’s capacity to activate all three within a unified experimental framework makes it applicable to multi-pathway convergence studies, receptor cross-talk investigation, and signaling hierarchy mapping in metabolic research models.
Retatrutide peptide is supplied as a lyophilised powder. Lyophilisation is a freeze-drying process that stabilises the compound in solid form for laboratory storage and preserves peptide and acyl modification integrity prior to experimental use.
Recommended handling conditions:
This compound is not intended for use outside approved laboratory environments
Each unit of Retatrutide peptide undergoes quality control testing prior to dispatch. Peptide purity is verified through high-performance liquid chromatography (HPLC), confirming compound concentration and the absence of significant impurities across both the peptide sequence and acyl modification components. Mass spectrometry is applied to validate molecular identity and confirm acylation integrity within the compound structure.
Batch-to-batch consistency is maintained through internal quality assurance standards across all production runs. Each pack size is accompanied by analytical documentation providing peptide purity data, molecular identity confirmation, and batch identifiers. This supports reproducible research peptide supply to institutions and laboratories in the United States and internationally, and meets the documentation requirements of structured tri-receptor pharmacology research programmes.
Retatrutide is a chemically synthesised acylated peptide analogue. Acylation is a chemical modification in which a fatty acid chain is attached to the peptide backbone โ a structural feature that influences the compound’s interaction with plasma proteins and its behaviour in aqueous laboratory environments. This modification class is studied in peptide research for its effect on receptor binding kinetics and compound stability under experimental conditions.
The peptide’s sequence is engineered to achieve balanced potency across all three target receptors โ GIPR, GLP-1R, and GCGR โ within a single molecular structure. Achieving concurrent multi-receptor engagement from a single peptide sequence requires structural optimisation at residue positions that determine contact geometry with each receptor’s orthosteric binding site. An orthosteric binding site is the primary binding location on a receptor where its natural ligand โ the molecule it is designed to bind โ makes contact. This structural engineering is itself a subject of investigation in comparative receptor pharmacology and peptide structure-activity relationship research.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Regenerative peptide blend of BPC-157, GHK-Cu, and TB500 for tissue repair and skin health.
Copper-binding tripeptide promoting skin regeneration, wound healing, and anti-aging. 50mg vial.
Thymosin Beta-4 acetate supporting tissue repair, inflammation control, and muscle recovery. 10mg.
Relaxin-derived analogue with anti-fibrotic and cardioprotective peptide properties. 5mg vial.
